Free Trial
→ Trump Treasure April 19 (From Paradigm Press) (Ad) Buy NRSN Stock  Free NRSN Stock Alerts

NeuroSense Therapeutics (NRSN) SEC Filings & 10K Form

NeuroSense Therapeutics logo
$1.04 -0.05 (-4.31%)
Closing price 03/27/2025 03:59 PM Eastern
Extended Trading
$1.02 -0.02 (-1.92%)
As of 03/27/2025 06:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent NeuroSense Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
03/27/2025
7:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2025
7:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/19/2025
8:13 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
01/06/2025
9:40 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/26/2024
3:47 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
12/23/2024
8:04 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2024
10:06 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2024
1:42 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2024
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
12/12/2024
4:08 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
12/04/2024
7:32 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
3:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/24/2024
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
11/22/2024
3:30 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
10/31/2024
3:59 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
8:45 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2024
7:35 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/24/2024
7:30 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
8:35 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/09/2024
8:13 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/06/2024
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
10/01/2024
5:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
09/30/2024
3:53 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
8:25 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
5:10 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
5:10 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2024
4:00 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/28/2024
6:05 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2024
7:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
8:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
8:24 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2024
8:29 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2024
8:11 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2024
7:05 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
7:20 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/27/2024
7:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
7:16 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/24/2024
8:20 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2024
3:42 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2024
4:24 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
Elon Warns: Exec Order 14024 Targets Dollar (Ad)

Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.

Go Here to Learn What's Happening and How to Prepare >>
06/17/2024
4:25 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/17/2024
4:22 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
6:14 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2024
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
05/20/2024
3:16 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form F-1/A
05/20/2024
8:02 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
8:02 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
9:21 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
3:01 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form D
Notice of Exempt Offering of Securities 
04/12/2024
3:30 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2024
3:30 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B5
04/10/2024
8:00 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2024
7:32 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
04/08/2024
11:15 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
04/05/2024
8:28 AM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2024
4:10 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
04/04/2024
3:31 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/04/2024
3:37 PM		NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NRSN) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners
Elon Warns: Exec Order 14024 Targets Dollar
Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...
Priority Gold | Sponsored
New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...
Paradigm Press | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
Elon Musk is helping print “new gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...
Golden Portfolio | Sponsored
A market crash is coming—here’s when
The stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...
Chaikin Analytics | Sponsored
Just Revealed: The chip company making AI look primitive
In his just-released video presentation, this renowned market strategist — who's been called "one of the most ...
InvestorPlace | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored